Total Payments
$655.62
2024 Payments
$250.47
Companies
10
Transactions
30
Medicare Patients
585
Medicare Billing
$26,977
Payment Breakdown by Category
Food & Beverage$655.62 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $655.62 | 30 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $273.93 | 11 | $0 (2024) |
| Lilly USA, LLC | $144.94 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $100.31 | 6 | $0 (2024) |
| Novo Nordisk Inc | $36.54 | 2 | $0 (2024) |
| Radius Health, Inc. | $21.31 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $17.90 | 1 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $16.54 | 1 | $0 (2023) |
| Amgen Inc. | $15.70 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $14.56 | 1 | $0 (2023) |
| Philips North America LLC | $13.89 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.47 | 13 | ABBVIE INC. ($65.97) |
| 2023 | $312.12 | 13 | ABBVIE INC. ($207.96) |
| 2022 | $93.03 | 4 | Lilly USA, LLC ($93.03) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: Medical Device | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Inflammation | ||||||
| 06/25/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Endocrinology | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $51.91 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: INSOMNIA | ||||||
| 04/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 350 | 695 | $53,093 | $14,686 |
| 2022 | 8 | 235 | 440 | $36,161 | $12,291 |
Total Patients
585
Total Services
1,135
Medicare Billing
$26,977
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 150 | $24,972 | $6,874 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 47 | $9,870 | $3,266 | 33.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 36 | 40 | $5,000 | $1,385 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,301 | $1,208 | 28.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 29 | 62 | $2,480 | $1,006 | 40.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 16 | $800.00 | $259.20 | 32.4% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 11 | 11 | $1,825 | $218.88 | 12.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 32 | $1,440 | $194.48 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 22 | $660.00 | $184.80 | 28.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 17 | $425.00 | $57.97 | 13.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 52 | $1,040 | $16.45 | 1.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 27 | 224 | $280.00 | $15.55 | 5.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 58 | $12,180 | $4,489 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 71 | $11,857 | $4,107 | 34.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 37 | 40 | $5,200 | $1,388 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,024 | $1,195 | 39.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 26 | 52 | $2,080 | $846.00 | 40.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 22 | $990.00 | $189.45 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 21 | $630.00 | $61.74 | 9.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 18 | 160 | $200.00 | $14.55 | 7.3% |
About Leon Culverson
Leon Culverson is a Family healthcare provider based in Bainbridge, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2022. The National Provider Identifier (NPI) number assigned to this provider is 1164170213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leon Culverson has received a total of $655.62 in payments from pharmaceutical and medical device companies, with $250.47 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($655.62).
As a Medicare-enrolled provider, Culverson has provided services to 585 Medicare beneficiaries, totaling 1,135 services with total Medicare billing of $26,977. Data is available for 2 years (2022–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Bainbridge, GA
- Active Since 03/16/2022
- Last Updated 03/16/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1164170213
Products in Payments
- VRAYLAR (Drug) $258.83
- MOUNJARO (Drug) $119.77
- FARXIGA (Drug) $50.17
- Ozempic (Drug) $36.54
- BREZTRI (Drug) $30.39
- JARDIANCE (Drug) $25.17
- Tymlos (Drug) $21.31
- AIRSUPRA (Drug) $19.75
- LEQVIO (Drug) $17.90
- QUVIVIQ (Drug) $16.54
- Otezla (Drug) $15.70
- UBRELVY (Drug) $15.10
- BELSOMRA (Drug) $14.56
- (CK7) Extended Holter (Device) $13.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bainbridge
Wesley Kelley, Np, NP
Family — Payments: $2,683
Family $2,683
Justin Anderson, Np, NP
Family — Payments: $1,950
Family $1,950
Mrs. Elizabeth Hollis, Np, NP
Family — Payments: $1,338
Family $1,338
Emily Conoly, Apnp, APNP
Family — Payments: $867.01
Family $867.01
Kelli Burress, Np, NP
Family — Payments: $804.27
Family $804.27
Martina Coy-Stout, Aprn, APRN
Family — Payments: $711.86
Family $711.86